A novel combined systemic inflammation-based score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization

A novel combined systemic inflammation-based score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization

Abstract Background There is currently limited information regarding the prognostic ability of the dNLR-PNI (the combination of the derived neutrophil-to-lymphocyte ratio [dNLR] and prognostic nutritional index [PNI]) for hepatocellular carcinoma (HCC). This study aimed to assess the predictive abil...

Full description

Bibliographic Details
Main Authors: Chang Liu, Lei Li, Wu-sheng Lu, Hua Du, Lu-nan Yan, Tian-fu Wen, Wu-ran Wei, Li Jiang, Ming-qing Xu
Format: Article
Language:English
Published: BMC 2018-02-01
Series:BMC Cancer
Subjects:
Hepatocellular carcinoma (HCC)
Transarterial chemoembolization (TACE)
Derived neutrophil-to-lymphocyte ratio (dNLR)
Prognostic nutritional index (PNI)
Systemic inflammation
Online Access:http://link.springer.com/article/10.1186/s12885-018-4121-3

Internet

http://link.springer.com/article/10.1186/s12885-018-4121-3

Similar Items